Malaysian Genomics signs strategic cooperation agreement to expand in the United Arab Emirates

United Arab Emirates (UAE), October 26, 2022–(ACN Newswire via SEAPRWire.com)– The Malaysian Genome Resource Center Berhad (Burkha: MGRC, 0155), the leading specialist in genomics and biopharmaceutics, today announced the signing of a strategic cooperation agreement. (SCA) defines partnerships to market and distribute the Dtect(R) range of genetic screening services for the group in the United Arab Emirates (UAE).

Consul General of the Malaysian Consulate in Dubai, Mohammed Fadli Omari Al Yaman. ED for Malaysian Genomics Azri Azerai; Co-founder/Director of Wellness by Design Dr. Lama Al-Naeli. Chairman of the Board of Directors of ASC, BALSAM and Wellness by Design Dr. Hisham Hakim; Executive Director of Balsam Health Services, Abdul Qader Awad. IAC CEO Nurul Faten Jasmee; ASC Director Kair Hakim and Secretary General of the Malaysian Business Council Ezwan Adnan [L-R]
ASC Director Ker Hakeem; ED for Malaysian Genomics Azri Azerai; Consul General of the Malaysian Consulate in Dubai, Mohammed Fadli Omari Al Yaman. Chairman of the Board of Directors of ASC, BALSAM and Wellness by Design Dr. Hisham Hakim; CEO of Balsam Health Services Abdul Qader Awad, CEO of IAC Nurul Faten Jasmee [L-R]

Other than Malaysian Genomics, the SCA includes the American Spine Center (ASC), which specializes in Dubai, UAE in spinal injuries and diseases of the spine. Balsam Health Services, a healthcare service provider in Dubai, UAE; Wellness by Design FZ LLC.

Within the SCA framework, Malaysian Genomics, ASC, Balsam and Wellness by Design will explore joint strategies for joint or allied projects that translate into innovative healthcare tools or solutions, while the role of the IAC is to support activities in priority areas, aligning parties and action With other organizations, where applicable. The IAC will also be the point of contact between the Malaysian genome, ASC and Balsam and Wellness by Design.

Noor Azri bin Dato Sri Noor Aziri, Executive Director of Genomics Malaysia, said: “The SCA will allow us to formally explore how the parties are working together, including technical trials and evaluation of Dtect screening tests for marketing in the UAE. The role of Malaysian Genomics will be is to provide technical and scientific support within the framework of the SCA. In addition, we are constantly looking for opportunities to partner with like-minded companies and organizations to expand our market reach for Dtect and our other services.”

Dr. Hisham Hakim, Chairman of ASC, BALSAM and Wellness by Design said, “We welcome this first step in our working relationship with Malaysian Genomics and IAC, and look forward to including Dtect to offer more options to our patients. We are committed to clinical and technology excellence as we provide coordinated patient care. With empathy and commitment while ensuring cost efficiency.”

Ms. Nurul Faten Jasmi, CEO of IAC, said: “There are plenty of opportunities to expand genetic screening services in the UAE and the Middle East and North Africa (MENA) region. We will provide coordination, business delivery and project management between parties during Dtect’s technical trials in the UAE. United, followed by commercial start-up and expansion across the MENA region.”

Malaysian Genome Resource Center Berhad: 0155 [BURSA: MGRC] [RIC: MGRC:KL] [BBG: MGRC:MK]http://www.mgrc.com.my/

Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Leave a Comment